Market Snapshot

BSE Sensex: 81332.72 1.62%
BSE 500: 36795.89 1.65%
BSE 200: 11475.13 1.74%
BSE 100: 26248.18 1.76%
BSE MidCap: 47706.67 2.12%
BSE SmallCap: 54294.35 1.00%
BSE BANKEX: 58638.77 0.86%
BSE IT: 41836.85 2.15%
Nifty 50: 24834.85 1.76%
Nifty 500: 23292.05 1.64%
Nifty 200: 14039.2 1.73%
Nifty 100: 25841.9 1.71%
Nifty Midcap 100: 57768.1 1.81%
Nifty Small 100: 18854 0.97%
Nifty IT: 40977.35 2.30%
Nifty PSU Bank: 7270.65 1.66%

News:

BHEL receives LOI for Rs 10,00...
Gujarat Themis Q1 PAT falls ov...
Power Grid Q1 PAT rises 3% YoY...
IndusInd Bank PAT rises to Rs ...
Cipla spurts as Q1 PAT rises 1...

Titan Biotech Ltd Share Price – BSE
Pharmaceuticals, Small Cap

Invest

26 Jul 2024 | 03:59 PM

580.55

0.10 (0.02%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Outperforms Index

122.56%

Return (1Y)

Beaten BSE Sensex by 100.64%
More Volatile

3.7%

Standard Deviation (1Y)

Higher than BSE Sensex by 2.89%
Consistent Performer

7/12

Months

beaten BSE Sensex
AxisDirect View

No View

52 Week High-Low

645

257

News & Announcements

Titan Biotech consolidated net profit rises 1.01% in the March 2024 quarter

58 days ago

Board of Titan Biotech recommends Final Dividend
59 days ago

Board of Titan Biotech recommends Final Dividend

29 - May - 2024 12:00 AM | 59 days ago

Titan Biotech announced that the Board of Directors of the Company at its meeting held on 29 May 2024, has recommended a Final dividend of Rs.2 per share (i.e.20%), subject to the approval of the shareholders.
Powered by Capital Market - Live News
Titan Biotech to announce Quarterly Result
67 days ago

Titan Biotech to announce Quarterly Result

21 - May - 2024 12:00 AM | 67 days ago

Titan Biotech will hold a meeting of the Board of Directors of the Company on 29 May 2024
Powered by Capital Market - Live News
Titan Biotech standalone net profit rises 173.33% in the December 2023 quarter
166 days ago

Titan Biotech standalone net profit rises 173.33% in the December 2023 quarter

12 - Feb - 2024 12:00 AM | 166 days ago

Net profit of Titan Biotech rose 173.33% to Rs 7.38 crore in the quarter ended December 2023 as against Rs 2.70 crore during the previous quarter ended December 2022. Sales rose 51.60% to Rs 45.98 crore in the quarter ended December 2023 as against Rs 30.33 crore during the previous quarter ended December 2022.
Particulars Quarter Ended
Dec. 2023 Dec. 2022 % Var.
Sales 45.98 30.33 52
OPM % 23.01 13.65 -
PBDT 10.76 4.28 151
PBT 9.93 3.63 174
NP 7.38 2.70 173
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

×

Online trading for clients based in USA and Canada is restricted. You can continue placing orders through mapped dealers offline

OK

vV5.0.0.6-60